Dafna Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

$390 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $761,255 - $1.5 Million	-4,728 Reduced 8.94%	48,145 $15.2 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $1.76 Million - $2.33 Million	10,700 Added 25.37%	52,873 $8.94 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $6.42 Million - $8.74 Million	-36,400 Reduced 46.33%	42,173 $9.15 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $1.06 Million - $1.34 Million	6,546 Added 9.09%	78,573 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $8.26 Million - $10.2 Million	43,141 Added 149.35%	72,027 $14.2 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $4.11 Million - $9.2 Million	-33,167 Reduced 53.45%	28,886 $6.5 Million
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $1.88 Million - $2.87 Million	-20,000 Reduced 24.37%	62,053 $7.85 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $952,407 - $1.27 Million	9,630 Added 13.3%	82,053 $10.4 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $239,203 - $344,622	-2,162 Reduced 2.9%	72,423 $9.49 Million
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $2.18 Million - $2.72 Million	21,585 Added 40.73%	74,585 $9.12 Million
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $537,250 - $679,750	5,000 Added 10.42%	53,000 $6.04 Million
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $2.99 Million - $4.17 Million	31,332 Added 187.98%	48,000 $5.77 Million
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $559,485 - $812,343	7,437 Added 80.57%	16,668 $1.69 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $186,420 - $351,630	3,000 Added 48.15%	9,231 $1.03 Million
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $376,414 - $722,297	6,231 New	6,231 $449,000
Q4 2019 Feb 14, 2020	SELL	$11.44 - $123.99 $128,036 - $1.39 Million	-11,192 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.05 - $27.35 $19,131 - $32,601	1,192 Added 11.92%	11,192 $183,000
Q2 2019 Aug 14, 2019	BUY	$20.02 - $20.02 $200,200 - $200,200	10,000 New	10,000 $200,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account